Randomised Placebo-Controlled Single Blind Study to Investigate Single Ascending Doses of GNbAC1 in Multiple Sclerosis Patients Followed by Open-label Extension With Repeated Doses of GNbAC1
Phase of Trial: Phase II
Latest Information Update: 15 Aug 2015
At a glance
- Drugs GNbAC1 (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors GeNeuro
- 03 Sep 2014 Results published in the Media Release.
- 28 May 2014 Last checked against ClinicalTrials.gov record.
- 14 Mar 2014 On 4 Nov 2013, GeNeuro reported the trial is completed however, ClinicalTrials.gov record was updated on 27 Jan 2014 to report the status as active, no longer recruiting with an estimated primary completion date of Feb 2014.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History